New HLA Loss of Heterozygosity Monitoring Assays available!
/We are proud to announce that we have recently developed six new HLA assays, targeting allele subgroup A and C from the Class I HLA group. The new assays will be a welcome addition to our increasingly popular HLA TRACE™ panel, extending the number of HLA assays available to our customers to 28.
The HLA TRACE™ Assays allow to indicate rapidly imminent post-HSCT HLA loss events. The timely detection of HLA LOH may form the basis for optimizing patient-tailored therapy.
The new HLA TRACE™ Assays and their targets:
211279 QTRACE® HLA Assay H104 A*01:01, 36:01
211280 QTRACE® HLA Assay H105 A*11:01/02
211281 QTRACE® HLA Assay H106 A*29
211282 QTRACE® HLA Assay H107 C*03:02/03/04/05/06
211283 QTRACE® HLA Assay H108 C*04:01
211284 QTRACE® HLA Assay H109 A*02:01/02/03/07
